|
1
|
Chu H, Li M and Wang X: Capsaicin induces
apoptosis and autophagy in human melanoma cells. Oncol Lett.
17:4827–4834. 2019.PubMed/NCBI
|
|
2
|
Mishra H, Mishra PK, Ekielski A, Jaggi M,
Iqbal Z and Talegaonkar S: Melanoma treatment: From conventional to
nanotechnology. J Cancer Res Clin Oncol. 144:2283–2302. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martens MC, Seebode C, Lehmann J and
Emmert S: Photocarcinogenesis and skin cancer prevention
strategies: An update. Anticancer Res. 38:1153–1158.
2018.PubMed/NCBI
|
|
4
|
Rick JW, Shahin M, Chandra A, Dalle Ore C,
Yue JK, Nguyen A, Yagnik G, Sagar S, Arfaie S and Aghi MK: Systemic
therapy for brain metastases. Crit Rev Oncol Hematol. 142:44–50.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chowdhary M, Patel KR, Danish HH, Lawson
DH and Khan MK: BRAF inhibitors and radiotherapy for melanoma brain
metastases: Potential advantages and disadvantages of combination
therapy. Onco Targets Ther. 9:7149–7159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nicholas S, Mathios D, Jackson C and Lim
M: Metastatic melanoma to the brain: Surgery and radiation is still
the standard of care. Curr Treat Options Oncol. 14:264–279. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mandala M and Voit C: Targeting BRAF in
melanoma: Biological and clinical challenges. Crit Rev Oncol
Hematol. 87:239–255. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alexandrescu DT, Ichim TE, Riordan NH,
Marincola FM, Di Nardo A, Kabigting FD and Dasanu CA: Immunotherapy
for melanoma: Current status and perspectives. J Immunother.
33:570–590. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shimanovsky A, Jethava A and Dasanu CA:
Immune alterations in malignant melanoma and current immunotherapy
concepts. Expert Opin Biol Ther. 13:1413–1427. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Walter L and Heinzerling L: BRAF
Inhibitors and radiation do not act synergistically to inhibit WT
and V600E BRAF human melanoma. Anticancer Res. 38:1335–1341.
2018.PubMed/NCBI
|
|
11
|
Gray TA, Azama K, Whitmore K, Min A, Abe S
and Nicholls RD: Phylogenetic conservation of the makorin-2 gene,
encoding a multiple zinc-finger protein, antisense to the RAF1
proto-oncogene. Genomics. 77:119–126. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang J, Xu Y, Ren H, Wudu M, Wang Q, Song
X, Su H, Jiang X, Jiang L and Qiu X: MKRN2 inhibits migration and
invasion of non-small-cell lung cancer by negatively regulating the
PI3K/Akt pathway. J Exp Clin Cancer Res. 37:1892018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hall TM: Multiple modes of RNA recognition
by zinc finger proteins. Curr Opin Struct Biol. 15:367–373. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Freemont PS: The RING finger. A novel
protein sequence motif related to the zinc finger. Ann N Y Acad
Sci. 684:174–192. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gray TA, Hernandez L, Carey AH, Schaldach
MA, Smithwick MJ, Rus K, Marshall Graves JA, Stewart CL and
Nicholls RD: The ancient source of a distinct gene family encoding
proteins featuring RING and C(3)H zinc-finger motifs with abundant
expression in developing brain and nervous system. Genomics.
66:76–86. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Borden KL: RING domains: Master builders
of molecular scaffolds? J Mol Biol. 295:1103–1112. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shin C, Ito Y, Ichikawa S, Tokunaga M,
Sakata-Sogawa K and Tanaka T: MKRN2 is a novel ubiquitin E3 ligase
for the p65 subunit of NF-κB and negatively regulates inflammatory
responses. Sci Rep. 7:460972017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu X, Li C, Gao X, Xia K, Guo H, Li Y, Hao
Z, Zhang L, Gao D, Xu C, et al: Excessive UBE3A dosage impairs
retinoic acid signaling and synaptic plasticity in autism spectrum
disorders. Cell Res. 28:48–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li C, Chen P, Zhang J, Zhang L, Huang X,
Yao Y, Che X, Fan X, Ge S and Wang Z: Enzyme-induced vitreolysis
can alleviate the progression of diabetic retinopathy through the
HIF-1α pathway. Invest Ophthalmol Vis Sci. 54:4964–4970. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Z, Chen P, Gao H, Gu Y, Yang J, Peng
H, Xu X, Wang H, Yang M, Liu X, et al: Ubiquitylation of autophagy
receptor Optineurin by HACE1 activates selective autophagy for
tumor suppression. Cancer Cell. 26:106–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD,
Lees E, Harper JW, Elledge SJ and Reed SI: p53-dependent inhibition
of cyclin-dependent kinase activities in human fibroblasts during
radiation-induced G1 arrest. Cell. 76:1013–1023. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
el-Deiry WS, Tokino T, Velculescu VE, Levy
DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and
Vogelstein B: WAF1, a potential mediator of p53 tumor suppression.
Cell. 75:817–825. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abreu AP, Macedo DB, Brito VN, Kaiser UB
and Latronico AC: A new pathway in the control of the initiation of
puberty: The MKRN3 gene. J Mol Endocrinol. 54:R131–R139. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee HK, Lee EW, Seo J, Jeong M, Lee SH,
Kim SY, Jho EH, Choi CH, Chung JY and Song J: Ubiquitylation and
degradation of adenomatous polyposis coli by MKRN1 enhances
Wnt/β-catenin signaling. Oncogene. 37:4273–4286. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee MS, Han HJ, Han SY, Kim IY, Chae S,
Lee CS, Kim SE, Yoon SG, Park JW, Kim JH, et al: Loss of the E3
ubiquitin ligase MKRN1 represses diet-induced metabolic syndrome
through AMPK activation. Nat Commun. 9:34042018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee EW, Lee MS, Camus S, Ghim J, Yang MR,
Oh W, Ha NC, Lane DP and Song J: Differential regulation of p53 and
p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis.
EMBO J. 28:2100–2113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee KY, Chan KY, Tsang KS, Chen YC, Kung
HF, Ng PC, Li CK, Leung KT and Li K: Ubiquitous expression of
MAKORIN-2 in normal and malignant hematopoietic cells and its
growth promoting activity. PLoS One. 9:e927062014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sane S and Rezvani K: Essential roles of
E3 ubiquitin ligases in p53 regulation. Int J Mol Sci. 18(pii):
E4422017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gupta A, Shah K, Oza MJ and Behl T:
Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for
cancer treatment. Biomed Pharmacother. 109:484–492. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Niazi S, Purohit M and Niazi JH: Role of
p53 circuitry in tumorigenesis: A brief review. Eur J Med Chem.
158:7–24. 2018. View Article : Google Scholar : PubMed/NCBI
|
